| NCT03322202 | Training Therapists in Motivational Interviewing | Shirley Ryan AbilityLab | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≥ 0 hours
| | 110 | NA | | Mental health and psychosocial factors | | | 16 November 2017 | 26 October 2017 | 1 | |
| NCT03345576 | Testosterone and Long Pulse Stimulation After SCI | VA Office of Research and Development | | - Age 18 - 70 yrs
- Level T10-S5
AIS A, B- ≥ 0 hours
| Ended | 12 | PHASE2 | Drug | Standing/walking/mobility | | | 01 July 2018 | 17 November 2017 | 1 | |
| NCT03267810 | TENS Trial to Prevent Neuropathic Pain in SCI | University of Miami | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≤ 4 months
| Ended | 31 | NA | Technology | Pain | | | 14 August 2017 | 30 August 2017 | 1 | |
| NCT03292315 | Once Weekly GLP-1 in Persons With Spinal Cord Injury | James J. Peters Veterans Affairs Medical Center | | - Age 18 - 69 yrs
- Level C1-S5
AIS D- 3 months - 69 years
| Ended | 5 | PHASE4 | Drug | General health | | | 16 October 2018 | 25 September 2017 | 1 | |
| NCT03262766 | Daily Intermittent Hypoxia and Task-Specific Upper Limb Training in Persons With Chronic Incomplete SCI | Shirley Ryan AbilityLab | | - Age 18 - 70 yrs
- Level C2-T1
AIS C, D- 1 years - 70 years
- have a spinal cord injury for at least 1 year.
- have a neurological level of injury between C2 and T1.
- have one of the following ASIA impairment scale (AIS):
- AIS C: incomplete; at least some feeling and mostly weak movement below the injury.
- AIS D: incomplete; at least some feeling and, some weak but mostly stronger movement below the injury).
- have the ability to close at least one hand without assistance.
- be between the ages of 18 to 70 years.
- weigh ≤ 250 pounds (114kg).
| | 80 | NA | | Arm/hand function | | | 24 June 2017 | 25 August 2017 | 1 | |
| NCT03229031 | A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury | Eusol Biotech Co., Ltd. | | - Age 18 - 65 yrs
- Level C1-S5
AIS A- ≤ 65 years
| Ended | 160 | PHASE3 | Drug | Standing/walking/mobility | | | 07 March 2018 | 25 July 2017 | 4 | |
